David S. Marlin is a Los Angeles, California based male Ophthalmologist who is specialized in Ophthalmology. Active license number of David S. Marlin is G62561 for Ophthalmology in California. David S. Marlin is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
David S. Marlin speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD
Gender:
Male
Practice Address:
4733 W Sunset Blvd, Los Angeles, California, 90027-6021
Phone:
323-783-4011
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1346317237
NPI Enumeration Date:
29 Nov, 2006
NPI Last Update On:
23 Sep, 2008
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for David S. Marlin are as mentioned below.
License Number
Specialization
State
Status
G62561
Ophthalmology
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
4733 W Sunset Blvd, Los Angeles, California
Zip:
90027-6021
Phone Number:
323-783-4011
Fax Number:
--
Patients can reach David S. Marlin at 4733 W Sunset Blvd, Los Angeles, California or can call to book an appointment on 323-783-4011. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.